View Cart (0 items)


The pharmaceutical industry develops, produces and markets drugs or pharmaceuticals licensed for sale as medications. Pharmaceutical companies make pharmaceutical preparations or finished drugs; biological products, such as serums, bulk chemicals and botanicals used in making finished drugs; and diagnostic substances such as pregnancy and blood glucose kits. Pharmaceutical processing encompasses the end-process formulations have to go through, including packaging, labeling, processing and formatting drugs into tablets, liquids and gels. Bio-pharma is a collection of technologies that capitalize on the attributes of cells, such as their manufacturing capabilities, and put, biological molecules, such as DNA and proteins, to work for us.


Bristol-Myers Squibb to build new biologics manufacturing plant in Ireland

The new manufacturing facility will produce multiple therapies for the biopharmaceutical company's growing portfolio of approved and investigational biologic medicines in therapeutic areas including oncology, virology and immunoscience.
Read More

Allergan enters acquisition deal with Actavis

Botox maker Allergan, Inc. will be acquired by Actavis plc for $66 billion after fending off a hostile takeover bid by activist investor William Ackman and Valeant Pharmaceuticals International Inc.
Read More

New Eastman copolyester for medical products could allow faster processing

A styrene-free alternative to high-impact polystyrene (HIPS) for opaque medical packaging has been introduced by Eastman Chemical Company in the European market.
Read More

Banned drugs found in dietary supplements after recalls

New research suggests that more rigorous regulatory oversight is needed in the dietary supplements industry.
Read More

Bayer Healthcare closes Dihon acquisition, invests in Versant fund

Bayer HealthCare, part of German chemical and pharmaceutical group Bayer AG, has completed its acquisition of Chinese pharmaceutical company Dihon Pharmaceutical Group Co., Ltd.
Read More

GlaxoSmithKline plans stock market sale of minority stake in HIV treatment company

British pharmaceutical group GlaxoSmithKline plc (GSK) is planning to spin off a subsidiary that focuses on developing treatments for HIV.
Read More

Novartis to sell influenza vaccines business for $275 million

Healthcare company Novartis has entered into an agreement to sell its influenza vaccines unit for $275 million.
Read More

PACK EXPO 2014 expected to set attendance records

PMMI, the Association for Packaging and Processing Technologies, predicts 2014 will set some new records for PACK EXPO International and the debut of Pharma EXPO.
Read More

Three Nigerian pharmaceutical firms get WHO certification

Three pharmaceutical manufacturers in Nigeria have been certified by the World Health Organization (WHO) to produce drugs in accordance with its Good Manufacturing Practice (GMP).
Read More

Auxilium Pharmaceuticals agrees to acquisition deal with Endo

Specialty biopharmaceutical company Auxilium Pharmaceuticals, Inc. is to be acquired by Endo International plc for $2.6 billion, including the repayment and assumption of debt.
Read More